{"id":289945,"date":"2020-04-22T15:59:01","date_gmt":"2020-04-22T12:59:01","guid":{"rendered":"https:\/\/www.nationalturk.com\/?p=289945"},"modified":"2020-04-22T15:59:01","modified_gmt":"2020-04-22T12:59:01","slug":"almanyada-turk-sirketi-atakta-asi-icin-insan-deneylerine-onay-verildi-289945","status":"publish","type":"post","link":"https:\/\/www.nationalturk.com\/tr\/almanyada-turk-sirketi-atakta-asi-icin-insan-deneylerine-onay-verildi-289945\/","title":{"rendered":"Almanya’da T\u00fcrk \u015firketi atakta: A\u015f\u0131 i\u00e7in insan deneylerine onay verildi"},"content":{"rendered":"

T\u00fcrk bilim insan\u0131 Prof. Dr. U\u011fur \u015eahin’in kurucu orta\u011f\u0131 oldu\u011fu biyoteknoloji firmas\u0131 BioNTech koronavir\u00fcs a\u015f\u0131s\u0131 i\u00e7in klinik ara\u015ft\u0131rma onay\u0131 ald\u0131.<\/p>\n

Yeni tip koronavir\u00fcs SARS-Cov-2’nin yol a\u00e7t\u0131\u011f\u0131 COVID-19’a kar\u015f\u0131 Almanya’da geli\u015ftirilen bir a\u015f\u0131 i\u00e7in klinik deney yapma izni \u00e7\u0131kt\u0131.<\/p>\n

Paul Ehrlich Enstit\u00fcs\u00fc (PEI) taraf\u0131ndan yap\u0131lan a\u00e7\u0131klamada, Mainz merkezli BioNTech firmas\u0131na geli\u015ftirdikleri etken maddenin insan \u00fczerinde denenmesi i\u00e7in izin verildi\u011fi bildirildi.<\/p>\n

PEI a\u00e7\u0131klamas\u0131nda “Almanya ve Almanya’da d\u0131\u015f\u0131ndaki toplumlar i\u00e7in insan \u00fczerinde deney yap\u0131lmas\u0131 koronavir\u00fcse kar\u015f\u0131 g\u00fcvenilir ve etkili bir a\u015f\u0131 bulunmas\u0131 konusunda \u00f6nemli bir mihenk ta\u015f\u0131d\u0131r” ifadeleri kullan\u0131ld\u0131.<\/p>\n

A\u015f\u0131 i\u00e7in T\u00fcrk \u015firketi ile Pfizer ortakl\u0131\u011f\u0131<\/h3>\n

\u00c7al\u0131\u015fmada bulunan a\u015f\u0131 d\u00fcnyaca \u00fcnl\u00fc Pfizer \u015firketi ile U\u011fur \u015eahin ve e\u015fi \u00d6zlem T\u00fcreci’nin kurucu ortaklar\u0131 ve y\u00f6neticileri aras\u0131nda oldu\u011fu BioNTech taraf\u0131ndan ortak olarak geli\u015ftirildi. U\u011fur \u015eahin Alman medyas\u0131na yapt\u0131\u011f\u0131 a\u00e7\u0131klamada “Klinik \u00f6ncesi deneyler tamamland\u0131. Bu y\u00fczden mutluyuz ve insan deneylerine beklenenden \u00e7ok daha h\u0131zl\u0131 ba\u015flayabiliriz” dedi.<\/p>\n

\u015eirketten yap\u0131lan a\u00e7\u0131klamaya g\u00f6re ise klinik deneylerde 18 ile 55 ya\u015flar\u0131 aras\u0131nda 200 sa\u011fl\u0131kl\u0131 g\u00f6n\u00fcll\u00fc kullan\u0131lacak.<\/p>\n

Klinik deneylerin 3 ila 5 ay aras\u0131nda s\u00fcrmesi bekleniyor.<\/p>\n

Koronavir\u00fcs salg\u0131n\u0131n\u0131n ba\u015flamas\u0131ndan bu yana en az 80 a\u015f\u0131 projesinin y\u00fcr\u00fct\u00fcld\u00fc\u011f\u00fc, \u00c7in ve ABD’deki ara\u015ft\u0131rmalarda en az 4 etken maddenin test edildi\u011fi bildiriliyor.<\/p>\n\n","protected":false},"excerpt":{"rendered":"

T\u00fcrk bilim insan\u0131 Prof. Dr. U\u011fur \u015eahin’in kurucu orta\u011f\u0131 oldu\u011fu biyoteknoloji firmas\u0131 BioNTech koronavir\u00fcs a\u015f\u0131s\u0131 i\u00e7in klinik ara\u015ft\u0131rma onay\u0131 ald\u0131. Yeni tip koronavir\u00fcs SARS-Cov-2’nin yol a\u00e7t\u0131\u011f\u0131 COVID-19’a kar\u015f\u0131 Almanya’da geli\u015ftirilen bir a\u015f\u0131 i\u00e7in klinik deney yapma izni \u00e7\u0131kt\u0131. Paul Ehrlich Enstit\u00fcs\u00fc (PEI) taraf\u0131ndan yap\u0131lan a\u00e7\u0131klamada, Mainz merkezli BioNTech firmas\u0131na geli\u015ftirdikleri etken maddenin insan \u00fczerinde denenmesi …<\/p>\n","protected":false},"author":4,"featured_media":289946,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6155,5005,6669,349],"tags":[220678,220460,220660,25805],"class_list":["post-289945","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gundem","category-manset","category-saglik","category-son-dakika","tag-biontech","tag-koronavirus-asisi","tag-manset","tag-pfizer"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/posts\/289945","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/comments?post=289945"}],"version-history":[{"count":0,"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/posts\/289945\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/media\/289946"}],"wp:attachment":[{"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/media?parent=289945"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/categories?post=289945"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/tags?post=289945"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}